Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Milk Thistle

Phase 2Small molecule

UUniversity of Chicago

1

Indications

4

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pediatric NAFLDRecruiting

Pediatric NAFLDPhase 2

Recruiting

Timeline

Expected Milestones

Q1 2029

Phase 2Recruiting

Pediatric NAFLD

NCT06477146

Clinical

Trials by Indication[1]

Pediatric NAFLD1 trial

Milk Thistle Clinical Trial in Pediatric NAFLD

Recruiting·UUniversity Hospitals Cleveland Medical Center·Phase 2·NCT06477146·20 enrolled

Trichotillomania1 trial

Milk Thistle in Trichotillomania in Children and Adults

Completed·UUniversity of Chicago·Phase 2·NCT02473913·22 enrolled

Pathological Gambling1 trial

Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study

Completed·UUniversity of Chicago·Phase 2·NCT02337634·55 enrolled

Unspecified1 trial

Milk Thistle in Body Dysmorphic Disorder

Withdrawn·UUniversity of Chicago·Phase 2·NCT02843451

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Milk Thistle. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Milk Thistle compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Milk Thistle. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Chicago company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Chicago

Related News